- Home
- IPAR vs AXSM Comparison
IPAR vs AXSM Comparison
Compare IPAR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPAR
- AXSM
- Stock Information
- Founded
- IPAR 1982
- AXSM 2012
- Country
- IPAR United States
- AXSM United States
- Employees
- IPAR N/A
- AXSM N/A
- Industry
- IPAR Package Goods/Cosmetics
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- IPAR Consumer Discretionary
- AXSM Health Care
- Exchange
- IPAR Nasdaq
- AXSM Nasdaq
- Market Cap
- IPAR 4.1B
- AXSM 4.2B
- IPO Year
- IPAR 1988
- AXSM 2015
- Fundamental
- Price
- IPAR $143.28
- AXSM $96.18
- Analyst Decision
- IPAR Strong Buy
- AXSM Strong Buy
- Analyst Count
- IPAR 5
- AXSM 13
- Target Price
- IPAR $159.40
- AXSM $130.69
- AVG Volume (30 Days)
- IPAR 110.3K
- AXSM 965.3K
- Earning Date
- IPAR 02-25-2025
- AXSM 02-18-2025
- Dividend Yield
- IPAR 2.10%
- AXSM N/A
- EPS Growth
- IPAR N/A
- AXSM N/A
- EPS
- IPAR 4.67
- AXSM N/A
- Revenue
- IPAR $1,419,560,000.00
- AXSM $338,457,000.00
- Revenue This Year
- IPAR $12.47
- AXSM $44.77
- Revenue Next Year
- IPAR $3.44
- AXSM $67.70
- P/E Ratio
- IPAR $30.64
- AXSM N/A
- Revenue Growth
- IPAR 9.22
- AXSM 51.47
- 52 Week Low
- IPAR $108.39
- AXSM $64.11
- 52 Week High
- IPAR $156.75
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- IPAR 70.42
- AXSM 59.04
- Support Level
- IPAR $127.21
- AXSM $91.81
- Resistance Level
- IPAR $133.71
- AXSM $95.36
- Average True Range (ATR)
- IPAR 3.83
- AXSM 4.95
- MACD
- IPAR 1.26
- AXSM 1.43
- Stochastic Oscillator
- IPAR 98.05
- AXSM 89.89
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.